Shaperon Inc

Company Profile

• Business description

  Shaperon Inc is a developer of innovative inflammasome inhibitors and nanobody therapeutics intended to develop novel treatments for various chronic inflammatory diseases, including atopic dermatitis, systemic inflammatory response syndrome, neuroinflammatory diseases, and chronic inflammation. It offers a range of drug candidates, including a gel-type atopic dermatitis drug for use in the treatment of systemic inflammatory response syndrome, neuroinflammatory diseases and for treating chronic inflammation. The company also provides immunotherapeutic products and a single-domain neutralizing antibody, enabling clients to improve patient’s quality of life by developing safe and efficacious drugs and immunotherapies.

• Contact

  Gangnam Ace Tower G9
  Suie 218 & 606, 174-10 Jagok-ro, Gangnam-gu
  Seoul06373
  KOR

  T: +82 260838315

  http://www.shaperon.com

• Sector

  Healthcare

  Stock type

  Defensive

• Industry

  Biotechnology

  Fiscal Year End

  31 December 2025

  Employees

  54